About Trulieve Cannabis Corp
- Industry: Pharmaceuticals
- Exchange: NEW YORK STOCK EXCHANGE, INC.
- Country: US
- Website: https://www.trulieve.com/
Frequently Asked Questions
What is the 52-week range for TRLV?
The 52-week high is $12.93 and the 52-week low is $7.82.
What is the P/E ratio for TRLV?
The P/E ratio data is currently unavailable.
What is the dividend yield for TRLV?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -44.03%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -41.55%.
What is the Price to Book (P/B) Ratio?
P/B ratio data is currently unavailable.
Analyst Recommendation Trends
Wall Street analyst consensus for TRLV over the last few months:
Latest TRLV News
Trulieve Cannabis (TRLV) Falls On Rescheduling Delay, Is It Now A Bargain?
Regulatory setback hits Trulieve Cannabis The decision by DEA Chief Judge Derek Julius to pause the federal cannabis rescheduling case immediately weighed on sector sentiment, with Trulieve Cannabis (TRLV) moving lower as investors reassessed expectations around the timing of regulatory change. That pause landed on a stock that had already cooled off in the near term. Trulieve Cannabis has dropped about 12% on a 1 day share price basis and is down 13% over the past week, yet still shows a 25%...
MSOS: Pause On Cannabis Rescheduling - And Why Trulieve Is A Sneaky Pick
AdvisorShares Pure US Cannabis ETF is reiterated as a Buy despite DEA rescheduling delays. Click to see MSOS valuation, Trulieve Cannabis upside, and key risks.
Cannabis Investors Were Betting On Washington, Then Washington Hit Pause
The DEA just hit pause on cannabis rescheduling, putting the sector’s biggest catalyst and a potentially massive 280E tax break back in limbo.
Cannabis Stocks Are Slumping. A Procedural DEA Delay Is to Blame.
Trulieve Cannabis falls after the Drug Enforcement Administration pauses pending rescheduling proceedings for a case that could federally recognize cannabis for medical use.
Crude Oil Rises Over 1%; Conagra Brands Earnings Top Views
U.S. stocks mixed: Dow fell over 200 points, while Nasdaq and S&P 500 rose; inflation cooled and Q2 GDP was revised higher.
Trulieve Sinks 14% as DEA Judge Pauses Cannabis Rescheduling Over GAO Report Flagging “Gaps”
Key TakeawaysTrulieve shares fell about 14% after a DEA administrative law judge paused the case on moving marijuana to Schedule III on Tuesday afternoon. The pause followed a September 23 GAO report on drug scheduling, which the parties opposing rescheduling used to ask for the stay.
Concentrix Posts Mixed Q3 Results, Joins Cal-Maine Foods And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
Concentrix plunged 10.6% premarket after weak guidance, despite an earnings beat; several other stocks also traded lower.
Why FingerMotion Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
FingerMotion jumped 18.1% premarket after agreeing to buy Newbit Technology for $2.3M cash; NewGenIvf led gainers at 187.2%, while Silexion fell 16.6%.
MSOS, TRLV Slide After Hours As DEA Judge Pauses Cannabis Rescheduling Case
DEA Chief Judge Derek Julius paused the cannabis rescheduling case on Tuesday afternoon.
What's going on in today's after hours session
After the closing bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Evogene (NASDAQ:EVGN) shares increased by 75.0% to $0.72 during Tuesday's after-market session. The company's market cap stands at $4.5 million. AIxCrypto Hldgs (NASDAQ:AIXC) stock moved upwards by
Trulieve Announces Exclusive Master Licensing Agreement with Connected for Florida and Texas
Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S, today announced a licensing deal with Connected for the exclusive rights to genetics, trademarks, and proprietary know-how to produce and sell Alien Labs and Connected branded cannabis products in Florida and Texas.
Trulieve Cannabis Corp. Added to S&P Total Market and S&P Completion Indices
Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that the company has been added to the S&P Total Market Index (TMI), S&P Completion Index (CI), and sector sub-indices S&P TMI Health Care and S&P CI Health Care.
2 Cannabis Stocks That Are Quietly Trouncing the Market in 2026
Trulieve and Cronos are turning stronger results into market-beating gains.
Trulieve Cannabis Announces It Has Been Added To S&P Total Market Index And S&P Completion Index
Also added to sector sub-indices S&P TMI Health Care and S&P CI Health Care.The S&P TMI is one of the broadest equity benchmarks published by S&P Dow Jones Indices, encompassing a wide range of U.S.
Trulieve: As Regulatory Headwinds Wane, Value Creation Is On The Cards
Trulieve Cannabis is reinitiated as a Buy, driven by regulatory catalysts and attractive valuation after a recent 81% rally. Click for this TRLV update.
'Let's Go All In On Cannabis' Grown Rogue's Obie Strickler & Josh Rosen
CEO and founder of Grown Rogue (GRUSF), Obie Strickler and CSO Josh Rosen explain why operations matter more than scale in the cannabis industry.
Trulieve to Open Medical Cannabis Dispensary in Dunwoody, Georgia
Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in Dunwoody, Georgia.
Trulieve Cannabis Opens New Medical Cannabis Dispensary In Dunwoody, Georgia
New DeKalb County location will host grand opening celebration Thursday, September 10TALLAHASSEE, Fla., Sept. 4, 2026 /CNW/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a